Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2.71M
-
Shares change
-
-190K
-
Total reported value, excl. options
-
$5.62M
-
Value change
-
-$449K
-
Number of buys
-
8
-
Number of sells
-
-15
-
Price
-
$2.08
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q2 2022
28 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q2 2022.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.71M shares
of 15M outstanding shares and own 18.1% of the company stock.
Largest 10 shareholders include DIMENSIONAL FUND ADVISORS LP (627K shares), RENAISSANCE TECHNOLOGIES LLC (622K shares), VANGUARD GROUP INC (375K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (287K shares), BERKSHIRE ASSET MANAGEMENT LLC/PA (189K shares), ACADIAN ASSET MANAGEMENT LLC (188K shares), BlackRock Inc. (140K shares), GEODE CAPITAL MANAGEMENT, LLC (74.7K shares), TWO SIGMA INVESTMENTS, LP (51.5K shares), and STATE STREET CORP (43K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.